Peptide History intermediate
GIP physiology, dual agonist design, incretin combination therapy
Field
By Encyclopeptide Editorial | 1 min read
peptide-history peptide oligopeptide
Overview
GIP physiology, dual agonist design, incretin combination therapy is a peptide compound with applications in research and therapeutics. Field
Chemical Identity
| Property | Value |
|---|---|
| Name | GIP physiology, dual agonist design, incretin combination therapy |
| Sequence | --- |
Milestone 028 |
| Length | 22 amino acids |
| Category | Peptide History |
Structure
GIP physiology, dual agonist design, incretin combination therapy belongs to the Peptide History class of peptides. Its structure and properties make it suitable for various research and therapeutic applications.
Applications
GIP physiology, dual agonist design, incretin combination therapy has been studied for its potential applications in:
- Biomedical research
- Drug discovery
- Diagnostic applications
- Therapeutic development
References
- Source: peptide-history.md
- Database: Wikipept Peptide Database
Test Your Knowledge
Reinforce what you learned about GIP physiology, dual agonist design, incretin combination therapy with interactive quizzes on Wikipept.
Take a Quiz on Wikipept